4.8 Article

Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2

Journal

NATURE GENETICS
Volume 34, Issue 3, Pages 308-312

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ng1170

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA105152, R01 CA105152-02] Funding Source: Medline

Ask authors/readers for more resources

Mice lacking the transcriptional repressor oncoprotein Gfi1 are unexpectedly neutropenic(1,2). We therefore screened GFI1 as a candidate for association with neutropenia in affected individuals without mutations in ELA2 (encoding neutrophil elastase), the most common cause of severe congenital neutropenia (SCN; ref. 3). We found dominant negative zinc finger mutations that disable transcriptional repressor activity. The phenotype also includes immunodeficient lymphocytes and production of a circulating population of myeloid cells that appear immature. We show by chromatin immunoprecipitation, gel shift, reporter assays and elevated expression of ELA2 in vivo in neutropenic individuals that GFI1 represses ELA2, linking these two genes in a common pathway involved in myeloid differentiation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available